Contact us here

Work package 7: Dissemination and communication

WP7 will run in parallel with the other packages during the entire lifecycle of the project and focuses on dissemination and communication of the project’s aims, objectives and results. Its key aim is the widest possible dissemination of the project’s results to both the research community and all other interested/identified stakeholders. IMI supports collaborative research projects and builds networks of industrial and academic experts to boost pharmaceutical innovation in Europe. WP7 aims to establish links with this community, facilitating effective communication with the other BD4BO projects to ensure that PIONEER’s objectives are well known.


  1. Communicate information to the public about the project and its implementation status.
  2. Coordinate communication between consortium members and the public through dedicated project website and social media platforms.
  3. Coordinate communication activities with other relevant research and stakeholder networks.
  4. Contribute to PIONEER pilot studies through the production of educational material where appropriate to increase knowledge of the designed tools amongst clinicians and patients.
  5. Provide for the dissemination of project developed platforms for use by the wider scientific community.
  6. Disseminate the results of the project to target audiences and key stakeholders, including policymakers.

Dissemination should be an active process in which tailor-made information is actively imparted to the appropriate audience. Critically, it should involve the conversion of the information into multiple forms so that the most appropriate and easily understood message is conveyed to each individual stakeholder.

WP7 Partners

European Association of Urology, European Cancer Patient Coalition, ecancer Global Foundation, Bayer and Sanofi.